Transforming Compliance, Strategy & Innovation Through Intelligent Automation

 

Regulatory Affairs is No Longer About Documentation —
It’s About Intelligence, Prediction & Decision Science.

 

As global regulations grow more complex and data-intensive, Data Science and Artificial Intelligence (AI) are fundamentally transforming how regulatory strategies are designed, executed, and defended.

This design session explores how AI, machine learning, and advanced analytics are reshaping regulatory affairs across drugs, devices, biologics, and herbal/nutraceutical products, enabling faster approvals, stronger compliance, and evidence-driven decision-making.

This session is designed for professionals and learners who want to move beyond traditional regulatory workflows and understand how modern regulatory intelligence actually works in practice.

---

Why This Session Matters

Regulatory affairs is undergoing a profound transformation:

Regulatory data volumes have exploded

Manual document review is no longer scalable

Agencies demand faster, evidence-based submissions

AI is increasingly referenced in FDA, EMA, and global guidance

Organizations that integrate AI into regulatory operations gain competitive advantage in:

Speed-to-market

Compliance accuracy

Risk prediction

Inspection readiness